Patents
Patents for C07K 17 - Carrier-bound or immobilised peptides; Preparation thereof (10,673)
09/2006
09/26/2006US7112654 Ligand for vascular endothelial growth factor receptor
09/26/2006US7112567 reactive entity (maleimide) coupled to the peptide conjugated to blood protein such as immunoglobulins, including IgG and IgM, serum albumin, ferritin, steroid binding proteins, transferrin, thyroxin binding protein, alpha -2-macroglobulin, haptoglobin, etc.
09/26/2006US7112562 Insulin conjugates and methods of use thereof
09/26/2006US7112430 Nucleic acid molecules encoding a transmembrane serine protease 10, the encoded polypeptides and methods based thereon
09/21/2006WO2006097694A2 Peptide synthesis supported by a soluble polymer
09/21/2006WO2006097693A1 Convergent solid phase peptide synthesis by reaction of two fragments bound to solid support
09/21/2006WO2002050303A3 Protein-protein interactions
09/21/2006US20060210587 Virus-like particles for the induction of autoantibodies
09/21/2006US20060210493 Peptide that binds to integrins
09/21/2006US20060210452 Very large scale immobilized polymer synthesis
09/21/2006CA2742202A1 Ifbm's to promote the specific attachment of target analytes to the surface of orthopedic implants
09/20/2006EP1702985A2 Preferred segments of neural thread protein and methods of using the same
09/20/2006EP1701950A1 Ecstasy haptens and immunogens
09/20/2006EP1701949A2 Assay for entactogens
09/20/2006EP1701948A1 Assay for entactogens
09/20/2006EP1276491B1 Tamandarin and didemnin analogs and methods of making and using them
09/20/2006EP1137669B1 Storage-stable composition comprising squaric acid activated carrier usable for immobilisation of compounds containing amine groups
09/20/2006CN1835769A KIM-1 antagonists and use to modulate immune system
09/19/2006US7109309 Peptide fructose and protein conjugate with the same
09/19/2006US7109301 Tenascin-C isoform as marker for neoplasias
09/19/2006US7109299 Peptides of sequence of amino acids where one or more of the peptidyl [ C(O)NR ] linkages (bonds) have been replaced by a non-peptidyl linkage; IL-5 antagonists treating asthma
09/19/2006US7109298 Pure polypeptide containing a fragment capable of binding to and inducing apoptosis in an HT-29 colon carcinoma cell
09/14/2006WO2006096847A1 Obestatin and its uses
09/14/2006WO2003089588A3 Novel molecules of the pyrin/nbs/lrr protein family and uses thereof
09/14/2006US20060205923 For detecting the presence of FIV antibodies in a biological sample, bycontacting a biological sample from an animal with the FIV polypeptide
09/14/2006US20060204966 selecting therapy for a human subject having a solid epithelial tumor that overexpresses ErbB2 comprising determining whether the tumor expresses p95ErbB2; reversible dual tyrosine kinase inhibitor of both ErbB2 and epidermal growth factor receptor
09/14/2006CA2599577A1 Nucleic acids and proteins and methods for making and using them
09/13/2006EP1700244A1 A method for designing surfaces
09/13/2006EP1700116A1 Trityl derivatives for enhancing mass spectrometry
09/13/2006EP1699418A2 Small peptides for the treatment of alzheimer's disease and other beta-amyloid protein fibrillogenesis disorders
09/13/2006CN1832959A Polyethelene glycol link glp-1 compounds
09/12/2006US7105650 Nucleotide sequences which code binding protein for use in taste simulation and food processing
09/12/2006US7105488 inhibiting a target G protein-coupled receptor (GPCR) by contacting a cell that expresses GPCR with an isolated GPCR-modulating peptide; inhibits a biological activity of GPCR by disrupting the structure; antitumor, prevents binding of a virus and subsequent infection
09/12/2006US7105333 Nucleic acid molecules encoding a transmembrane serine protease 9, the encoded polypeptides and methods based thereon
09/12/2006US7105149 Isolation of five novel genes coding for new Fc receptors-type melanoma involved in the pathogenesis of lymphoma/myeloma
09/08/2006WO2006093794A1 Heterodimeric protein binding compositions
09/08/2006WO2006092043A1 Polymer entrapped particles
09/08/2006WO2006047417A3 Detection of cannabinoid receptor biomarkers and uses thereof
09/08/2006CA2599265A1 Heterodimeric protein binding compositions
09/07/2006US20060198855 Uses of DC-SIGN and DC-SIGNR for inhibiting hepatitis C virus infection
09/06/2006EP1697406A1 Protein separation device
09/06/2006EP1697405A1 Lsa-5 liver stage and blood stage antigen of plasmodium falciparum, immunogenic composition comprising said antigen, and vaccines against malaria
09/06/2006EP1507792B1 Device for the presentation of peptides or proteins, method for the preparation and use thereof
09/06/2006EP1214350B1 Peptides for combating the autoantibodies that are responsible for dilatative cardiomyopathy (dcm)
09/06/2006EP0760857B9 Receptor for oncostatin m
09/06/2006CN1829732A Imageable animal model of SARS infection
09/06/2006CN1273589C Conjugation of polypeptides
09/05/2006US7101974 Tumor necrosis factor ptotein; for use in the treatment of rheumatic diseases and arthritis
09/05/2006US7101966 Selection of peptide ligands specific for baculovirus DNA-binding protein from the FliTrx™ random peptide display library
09/03/2006CA2499657A1 Polymer entrapped particles
08/2006
08/31/2006US20060194953 Antibody purification by protein a and ion exchange chromatography
08/31/2006US20060194940 Water-soluble polymer alkanals
08/31/2006US20060194283 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/31/2006US20060194258 Polypeptide array synthesis
08/31/2006US20060194219 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/31/2006US20060193868 graphitic nanotubes substituted with chemical moieties or upon which certain cyclic compounds are adsorbed; complex structures comprised of such functionalized fibrils linked to one another; introducing functional groups onto the surface of such fibrils
08/31/2006CA2598889A1 Compositions and methods for classifying biological samples
08/30/2006CN1826528A Gelatin based substrate for protein-biochips
08/30/2006CN1823736A Process to make a sustained release formulation
08/29/2006US7097837 Synthetic vaccine agents
08/24/2006WO2006088214A1 Mictoactuator using bundled actin filaments
08/24/2006US20060188916 Joining spacer to biopolymers; generate spacer, join to bioplymer, recover biopolymer; conjugation that can be carried out entirely in the solid phase, with minimal disruption to automated synthetic protocols
08/24/2006US20060188513 Novel inhibin-related multiple antigenic peptide compositions that enhance production performance in avians
08/24/2006CA2597912A1 Method for detecting misfolded proteins and prions
08/23/2006EP1692514A1 Binding assay components
08/23/2006EP1691820A2 Preparation and composition of inter-alpha inhibitor proteins from human plasma for therapeutic use
08/22/2006US7094880 Decorin proteoglycan inhibitor of fibrinogen blood clotting
08/22/2006US7094879 Genetically engineered P30 antigen, improved antigen cocktail, and uses thereof
08/22/2006US7094876 Human cDNAs and proteins and uses thereof
08/22/2006US7094868 Peptides for recognition and targeting of GLIAL cell tumors
08/22/2006US7094580 Methods for producing pure perlecan and other heparan sulfate proteoglycans
08/22/2006US7094552 Diagnostic test kits
08/22/2006US7094409 Antigen arrays for treatment of allergic eosinophilic diseases
08/17/2006WO2006084888A2 C-terminally pegylated growth hormones
08/17/2006WO2005016116A3 Hemostatic devices containing a protein precipitate
08/17/2006WO2003087124A3 Hmgn2 peptides and related melecules that selectively home to tumor blood vessels and tumor cells
08/17/2006WO2003066831A3 Angiogenesis genes
08/17/2006DE102005005828A1 Makroporöses Kunststoffperlenmaterial Macroporous plastics bead material
08/16/2006CN1820018A Pharmaceutical compositions preparation of peptides, secreted by the snake venom glands
08/16/2006CN1819837A TAMANDARIN analogs and fragments thereof and methods of making and using
08/15/2006US7091319 IL-3 variant hematopoiesis fusion protein
08/15/2006US7091315 heterologous polypeptide is the Fc domain of immunoglobulins, used to stimulate biosynthesis of interferons, or for diagnosis or prophylaxis of diseases; immunostimulants
08/15/2006US7090993 Method of assaying pyrrole-containing biological compounds
08/15/2006US7090835 Modified colony stimulating factor for treatment of hematopoietic disorder
08/10/2006WO2006083276A2 Interferon-alpha polypeptides and conjugates
08/10/2006WO2006083016A1 Substrates for use in detection of phosphorylation-dephosphorylation reaction and detection method using the same
08/10/2006WO2006026097A3 Pegylation of antibodies against hiv
08/10/2006WO2003065999A3 Proliferated cell lines and uses thereof
08/10/2006CA2830588A1 Conjugation of streptococcal capsular saccharides
08/09/2006EP1687421A2 A process for producing exogenous protein in the milk of trangenic mammals and a process for purifying proteins therefrom
08/09/2006CN1816351A Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof
08/08/2006US7087737 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cell proliferative and tumor disorders
08/08/2006US7087732 Nucleotides and analogs having photoremovable protecting groups
08/08/2006US7087719 Isolation of crystalline colloid for treatment of severe edema, pancreatitis, adult respiratory distress syndrome (ARDS), liver disorders and burn injuries
08/08/2006US7087717 Comprises nucleotide sequences coding nuclear hormone receptor co-activator for diagnosis and treatment of liver disorders
08/08/2006US7087714 Mu-Opiod receptor splice variant polypeptides
08/08/2006US7087235 Fusion protein of streptococcal pyrogenic exotoxins
08/08/2006US7087231 In situ diagnosis of malaria
08/03/2006WO2006080895A1 Water-soluble, surface-functionalized nanoparticle for bioconjugation via universal silane coupling
08/03/2006WO2006057997A3 Plasmin-inhibitory therapies
1 ... 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 ... 107